<0> CovidienRhonda Luniak, 303-305-2263Vice PresidentR&MS CommunicationsorBruce Farmer, 508-452-4372Vice PresidentPublic RelationsorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor ...
The Nellcor Bedside SpO2 Patient Monitoring System provides clinicians with access to real-time patient respiratory status information including continuous SpO2, pulse rate monitoring and trending ...
DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...
Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...
International healthcare products major, Covidien plc ( COV) has started labeling its Nellcor pulse oximeters to promote the usefulness of the product line for Critical Congenitial Heart Disease (CCHD ...
The U.S. Food and Drug Administration has granted Covidien 510(k) clearance to market the company’s Nellcor Bedside SpO2 Patient Monitoring System. The Nellcor Bedside SpO2 system with OxiMax ...
Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE)-- Covidien, a leading global provider of healthcare products and recognized ...
BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...
Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...
Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care solutions, today announced the U.S. Food and Drug ...
Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the European Economic Area (EEA), Australia ...
Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback